Research and development teams in the field of synthetic and digital biology are applying data science methodologies and harnessing huge amounts of data captured from the natural world to design new biological experiments. Ultimately, the goal is to gain a better understanding of molecular cell biology in order to reconfigure organisms and/or their specific components. This, in turn, will help us cure diseases and improve aspects of human biology. Furthermore, it’s hoped that gaining insight into the fundamental building blocks of nature will yield solutions to the unfolding climate crisis.
The biggest innovations of the 21st century will be at the intersection of biology and technology. A new era is beginning. — Steve Jobs
Stephen Larson, CEO of MetaCell – a leading neuroscience software development company – describes digital biology as a field of research which “uses powerful simulation software to understand the basic functions of life… to give us a chance to understand malfunctions of human life, such as disease and ageing”.
Researchers and developers have been exploring the components of living organisms for decades, attempting to replicate biological functions in digital form. In 2012, Karr et al created a “first draft” of the working life systems of a simple bacterium, by modulating its individual biological processes.
More recently, Larson founded OpenWorm, an open-source platform which is uniting global digital biology specialists in creating the first virtual organism – a roundworm called c. elegans. It’s hoped that in building a full digital replica of this simple creature’s life systems, the scientific community will gain a deeper understanding of the complex systems that make up all living things.
Digital biology is helping researchers gain insight into some of the key medicinal and environmental problems that have evaded science for centuries. Applications of digital biology include:
Where digital biology is about discovering how living things work at a cell molecular level, synthetic biology centres on biological redesign – i.e. enhancing an organism by altering its DNA make-up. Synthetic biologists sew together long strands of DNA, which could come from different sources or be entirely novel, then insert them into an organism’s gene sequence to change its characteristics.
Gene editing falls under the umbrella of synthetic biology, but there’s a subtle difference in that, here, genetic scientists use tools to make very small changes to an organism’s existing DNA. A well-known example of this approach is CRISPR, which uses gene-editing technology to make precision changes to tiny components of DNA. A key goal of this pioneering bioscience is to eradicate genetic malfunctions which can lead to diseases including cancer, blood disorders and muscular dystrophy, etc.
But it’s not just the human condition that scientists are targeting through synthetic biology. The National Human Genome Research Institute (NIH) is also focusing its research and development efforts on areas such as crop production, to enhance yields and nutrients in the battle to feed the growing population. They are also looking at how to re-engineer organisms to help tackle the climate crisis.
Research and development projects dealing with vast quantities of data and large sample sizes are already benefitting from the digitalisation of biological testing, such as genome sequencing.
Digitalisation produces significantly more data than current analogue study methods, allowing scientists to apply machine learning and advanced data analytics to gain real-time insights into biological functions and build a picture of, for example, cell molecular biology over time. This can transform the pharma and healthcare industries by facilitating critical processes such as antibody discovery and taking potential medicines to clinical trials.
It could be argued that the complexity and unpredictability of biological study mean that more human touch is needed. There’s also concern around data protection, cybersecurity and the potential for bioterrorism due to the nature of open-source work in the field.
As digitalization continues to advance across all aspects of life—and as population growth, climate change, and disease accelerate—traditional life science study methods must evolve to keep pace.
We will be happy to hear your opinion and ideas concerning the potential of digital biology for helping scientists solve fundamental medicinal and environmental problems. Feel free to leave your comments below or get in touch with us.
Digital biology is a next-generation scientific field that combines biology and modern technology to model, simulate, and understand biological systems using computational tools and large-scale data analysis. Digital biology accelerates medical, healthcare, genetic, and environmental scientific discoveries by translating complex life processes into digital formats. So, researchers can address challenges such as disease mechanisms, antibiotic resistance, and sustainable energy development more efficiently and accurately.
There are several areas of biological study where technologies streamline research and optimise processes, including precision medicine, molecular engineering, human genome research and gene editing technologies like CRISPR. The technological use cases range from machine learning algorithms for biological data analysis and advanced simulation platforms to genome sequencing software. Also, scientists can use digital twins in healthcare to simulate organisms, bioinformatics tools to analyse complex data, and AI to accelerate drug discovery.
Scientists can apply artificial intelligence to analyse complex datasets, model biological systems, and optimise biological research processes. Using AI algorithms for clinical trials can facilitate drug discovery. In the lab, AI algorithms can identify promising drug candidates faster than traditional methods by analysing protein structures and genetic sequences. Machine learning is a powerful tool for processing substantial datasets generated by biological research. For example, MIT and McMaster University researchers have successfully identified a new antibiotic capable of fighting drug-resistant
The breadth of knowledge and understanding that ELEKS has within its walls allows us to leverage that expertise to make superior deliverables for our customers. When you work with ELEKS, you are working with the top 1% of the aptitude and engineering excellence of the whole country.
Right from the start, we really liked ELEKS’ commitment and engagement. They came to us with their best people to try to understand our context, our business idea, and developed the first prototype with us. They were very professional and very customer oriented. I think, without ELEKS it probably would not have been possible to have such a successful product in such a short period of time.
ELEKS has been involved in the development of a number of our consumer-facing websites and mobile applications that allow our customers to easily track their shipments, get the information they need as well as stay in touch with us. We’ve appreciated the level of ELEKS’ expertise, responsiveness and attention to details.